Literature DB >> 16732465

Adjunctive olanzapine treatment in bipolar adolescents responding insufficiently to mood stabilizers. Four case reports.

F Neslihan Inal Emiroglu1, Ozlem Gencer, Aylin Ozbek.   

Abstract

This report was aimed to evaluate the efficacy of olanzapine treatment as an adjunct therapy to mood stabilizers in the treatment of four adolescents responding insufficiently to mood stabilizers. All patients were diagnosed with bipolar I disorder according to DSM IV criteria. YMRS (Young mania rating scale) and CGI (Clinical global impression, improvement and therapeutic effectiveness scales) were used to evaluate overall response of the episode to the drugs. All patients with no adequate response to mood stabilizers did respond to adjunctive olanzapine treatment (10-30 mg/per day). It has been suggested that antipsychotics may be useful as an adjunct to mood stabilisers in bipolar disorder. However, further research is warranted regarding the use of atypical antipsychotics in children and adolescents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16732465     DOI: 10.1007/s00787-006-0552-5

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  10 in total

1.  A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder.

Authors:  J A Frazier; J Biederman; M Tohen; P D Feldman; T G Jacobs; V Toma; M A Rater; R A Tarazi; G S Kim; S B Garfield; M Sohma; J Gonzalez-Heydrich; R C Risser; Z M Nowlin
Journal:  J Child Adolesc Psychopharmacol       Date:  2001       Impact factor: 2.576

2.  Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder.

Authors:  E Vieta; M Reinares; B Corbella; A Benabarre; I Gilaberte; F Colom; A Martínez-Arán; C Gastó; M Tohen
Journal:  J Clin Psychopharmacol       Date:  2001-10       Impact factor: 3.153

3.  A rating scale for mania: reliability, validity and sensitivity.

Authors:  R C Young; J T Biggs; V E Ziegler; D A Meyer
Journal:  Br J Psychiatry       Date:  1978-11       Impact factor: 9.319

Review 4.  Tardive dyskinesia in affective disorders.

Authors:  J M Kane
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

5.  Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group.

Authors:  M Tohen; T G Jacobs; S L Grundy; S L McElroy; M C Banov; P G Janicak; T Sanger; R Risser; F Zhang; V Toma; J Francis; G D Tollefson; A Breier
Journal:  Arch Gen Psychiatry       Date:  2000-09

6.  Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol.

Authors:  G D Tollefson; T M Sanger; Y Lu; M E Thieme
Journal:  Arch Gen Psychiatry       Date:  1998-03

7.  Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group.

Authors:  M Tohen; T M Sanger; S L McElroy; G D Tollefson; K N Chengappa; D G Daniel; F Petty; F Centorrino; R Wang; S L Grundy; M G Greaney; T G Jacobs; S R David; V Toma
Journal:  Am J Psychiatry       Date:  1999-05       Impact factor: 18.112

8.  Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children.

Authors:  Joseph Biederman; Eric Mick; Paul Hammerness; Theresa Harpold; Megan Aleardi; Meghan Dougherty; Janet Wozniak
Journal:  Biol Psychiatry       Date:  2005-10-01       Impact factor: 13.382

9.  Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.

Authors:  Mauricio Tohen; K N Roy Chengappa; Trisha Suppes; Robert W Baker; Carlos A Zarate; Charles L Bowden; Gary S Sachs; David J Kupfer; S Nassir Ghaemi; Peter D Feldman; Richard C Risser; Angela R Evans; Joseph R Calabrese
Journal:  Br J Psychiatry       Date:  2004-04       Impact factor: 9.319

10.  A pilot family study of childhood-onset mania.

Authors:  J Wozniak; J Biederman; E Mundy; D Mennin; S V Faraone
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-12       Impact factor: 8.829

  10 in total
  3 in total

Review 1.  The safety of olanzapine in young children: a systematic review and meta-analysis.

Authors:  Jacqueline Flank; Lillian Sung; Christopher C Dvorak; Wendy Spettigue; L Lee Dupuis
Journal:  Drug Saf       Date:  2014-10       Impact factor: 5.606

2.  National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.

Authors:  Jonathan S Comer; Mark Olfson; Ramin Mojtabai
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-09-01       Impact factor: 8.829

3.  Pediatric bipolar disorders: from the perspective of Turkey.

Authors:  F Neslihan Inal Emiroglu; Rasim Somer Diler
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.